Investor Relations

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Stock Quote
CADX - (NASDAQ)
$13.98  
Mar 18, 2014
4:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.